SYMBICORT 320 / 9UG / DOSE INHALER 60 DOSES

* Turbuhaler. 320/9 microg/inhalation. Inhalation powder 60 doses.
* 1 dose (1 inhalation) contains: 320 mcg budesonide, 9 mcg formoterol fumarate dihydrate and approx. 491 mcg lactose monohydrate.
* Therapeutic Indications:
& & # Asthma:
& & – Regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta2-agonist) is appropriate.
& & – patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting beta2-agonists or
& & – patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
& & # COPD: Symptomatic treatment of patients with severe COPD (FEV1< 50% predicted normal) and a history of exacerbations,
& & who have significant symptoms despite regular therapy with long-acting bronchodilators.
* Recommended doses:
& & # Asthma:
& & – Adults (18 years and older): 1 inhalation twice daily. Some patients may require up to a maximum of 2 inhalations twice daily.
& & – Adolescents (12-17 years): 1 inhalation twice daily.
& & – Children under 12 years: Efficacy and safety have not been fully studied in children.
& & Symbicort 320/9 micrograms is not recommended for children under 12 years of age.
& & # COPD:
& & – Adults: 1 inhalation twice daily.
* To be taken as directed by the physician.
* N.B.: Replace the cover properly after use.
* Do not store above 30 degrees. Keep the container tightly closed.
* Packed by: AstraZeneca – Egypt. Under License of: AstraZeneca Sweden.
& & SYMBICORT is a Trade Mark of AstraZeneca group of companies.